Vaccines for human fungal diseases: close but still a long way to go
Abstract Despite the substantial global burden of human fungal infections, there are no approved fungal vaccines to protect at risk individuals. Here, we review the progress that has been made and the challenges that lie ahead in the quest towards efficacious fungal vaccines. In mouse studies, prote...
Guardado en:
Autores principales: | Lorena V. N. Oliveira, Ruiying Wang, Charles A. Specht, Stuart M. Levitz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3533b1cf9858451ca3dd793cf9e1cccc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cancer: Still a contraindication for allergen immunotherapy?
por: David El-Qutob, et al.
Publicado: (2021) -
Lung eosinophils elicited during allergic and acute aspergillosis express RORγt and IL-23R but do not require IL-23 for IL-17 production.
por: Bhawna Yadav, et al.
Publicado: (2021) -
Still a long way to go for tunisian democracy /
por: Ghilès, Francis
Publicado: (2013) -
Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study
por: Marukutira T, et al.
Publicado: (2014) -
Greater ethnic diversity correlates with lower HIV prevalence in Africa: justification for an alloimmunity vaccine
por: Zamani C, et al.
Publicado: (2013)